We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
I am a clinical cardiologist and physician-scientist with a board-certification in cardiology and multimodality noninvasive cardiac imaging. My clinical focus is on managing the side effects of cancer therapies on the heart, masses in the heart, including metastasis and clots, and coexisting cardiovascular disease in patients with cancer.
Read more
I work closely with a multidisciplinary cancer care team to provide cardiovascular care to patients who are undergoing cancer surgeries, cancer therapies, and radiation therapyas well as provide long-term cardiovascular care for cancer survivors.
My research focuses on studying cardiac metastasis and cardiac side effects from anticancer medications and radiation therapy. To better understand the mechanisms of cardiotoxicity at the genomic level, I use a combination of specialized cardiac imaging tests and translational laboratory research that use a precision medicine platform as well as stem cell derived cells found in the heart and blood vessels.
My Role at MSK
A cardiologist is a doctor with special training in the cardiovascular system (heart and blood vessels).
MD, PhD, University of Illinois at Urbana-Champaign
Residencies
Internal Medicine, Johns Hopkins Medical Institution
Fellowships
Cardiology, University of Florida
Cardio-oncology, Memorial Sloan Kettering Cancer Center
Advanced cardiac imaging, Memorial Sloan Kettering Cancer Center
Board Certifications
Internal Medicine
Cardiovascular Disease
Cardiovascular MRI
Cardiovascular CT
Nuclear Cardiology
Echocardiography
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
Aetna
In Network Coverage Type HMO, EPO PPO, POS, Transplant
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Visit PubMed for a full listing of Dr. Chan’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
We strive to keep reviews trustworthy, honest and fair.
Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Angel T. Chan discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
